Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shun Lu

Showing results (41-50 of 703) with videos related to

Pageof 71
Sort By:
Medical Oncology (Northwood, London, England)|December 1, 2010
Third-line therapy for advanced non-small-cell lung cancer patients: feasible drugs for feasible patientsZhengbo Song, Yongfeng Yu, Zhiwei Chen, et al.
Oncotarget|March 10, 2015
NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10Yingjia Sun, Xinghao Ai, Shengping Shen, et al.
Biochimie|March 15, 2015
An interaction map of small-molecule kinase inhibitors with anaplastic lymphoma kinase (ALK) mutants in ALK-positive non-small cell lung cancerXinghao Ai, Shengping Shen, Lan Shen, et al.
Cancer Medicine|May 21, 2024
A large-scale, multicenter characterization of BRAF G469V/A-mutant non-small cell lung cancerHan Wu, Jian Feng, Shun Lu, et al.
Applied Optics|December 18, 2023
MIMO detection using an ALR-CNN in SDM transmission systemsDanni Zhang, Xinyuan Ma, Shun Lu, et al.
Amino Acids|March 25, 2014
A systematic profile of clinical inhibitors responsive to EGFR somatic amino acid mutations in lung cancer: implication for the molecular mechanism of drug resistance and sensitivityXinghao Ai, Yingjia Sun, Haidong Wang, et al.
Plos One|October 24, 2018
Cost-effectiveness of ALK testing and first-line crizotinib therapy for non-small-cell lung cancer in ChinaShun Lu, Yongfeng Yu, Shijun Fu, et al.
Materials (Basel, Switzerland)|June 19, 2024
Structural Design of Nickel Hydroxide for Efficient Urea ElectrooxidationYi Zeng, Shouqin Xiang, Shun Lu, et al.
Chinese Medical Journal|January 19, 2010
Pemetrexed monotherapy versus pemetrexed plus platinum combination as second-line treatment for advanced non-small cell lung cancerYi-fei Zhang, Zhi-wei Chen, Shun Lu
Chemical Communications (Cambridge, England)|February 24, 2026
Atomically dispersed Ru-Co pairs on hollow carbon as robust catalysts for the acidic oxygen evolution reactionFengqin Zhang, Qingmei Wang, Zhijie Chen, et al.
Pageof 71

Showing results (41-50 of 703) with videos related to

Sort By:
Pageof 71
Medical Oncology (Northwood, London, England)|December 1, 2010
Third-line therapy for advanced non-small-cell lung cancer patients: feasible drugs for feasible patientsZhengbo Song, Yongfeng Yu, Zhiwei Chen, et al.
Oncotarget|March 10, 2015
NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10Yingjia Sun, Xinghao Ai, Shengping Shen, et al.
Biochimie|March 15, 2015
An interaction map of small-molecule kinase inhibitors with anaplastic lymphoma kinase (ALK) mutants in ALK-positive non-small cell lung cancerXinghao Ai, Shengping Shen, Lan Shen, et al.
Cancer Medicine|May 21, 2024
A large-scale, multicenter characterization of BRAF G469V/A-mutant non-small cell lung cancerHan Wu, Jian Feng, Shun Lu, et al.
Applied Optics|December 18, 2023
MIMO detection using an ALR-CNN in SDM transmission systemsDanni Zhang, Xinyuan Ma, Shun Lu, et al.
Amino Acids|March 25, 2014
A systematic profile of clinical inhibitors responsive to EGFR somatic amino acid mutations in lung cancer: implication for the molecular mechanism of drug resistance and sensitivityXinghao Ai, Yingjia Sun, Haidong Wang, et al.
Plos One|October 24, 2018
Cost-effectiveness of ALK testing and first-line crizotinib therapy for non-small-cell lung cancer in ChinaShun Lu, Yongfeng Yu, Shijun Fu, et al.
Materials (Basel, Switzerland)|June 19, 2024
Structural Design of Nickel Hydroxide for Efficient Urea ElectrooxidationYi Zeng, Shouqin Xiang, Shun Lu, et al.
Chinese Medical Journal|January 19, 2010
Pemetrexed monotherapy versus pemetrexed plus platinum combination as second-line treatment for advanced non-small cell lung cancerYi-fei Zhang, Zhi-wei Chen, Shun Lu
Chemical Communications (Cambridge, England)|February 24, 2026
Atomically dispersed Ru-Co pairs on hollow carbon as robust catalysts for the acidic oxygen evolution reactionFengqin Zhang, Qingmei Wang, Zhijie Chen, et al.
Pageof 71